Moving forward with a phase 1 trial

Dr. Bernard Thébaud and colleagues have received a $638,000 grant from the Stem Cell Network with in-kind matching funds from MDTB Cells GmbH to conduct a phase I clinical trial of umbilical cord cell therapy for premature babies. This trial aims to determine if this...